Subtype
Bone Neoplasm
CI-CAN-00000569Explore in graph →
Non-malignant65 active trials4 approved drugs16 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000569Explore in graph →
Clinical trials
342 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04255576 | Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone | unknown | Phase 1 / Phase 2 | 139 | Shanghai JMT-Bio Inc.INDUSTRY | 1 | Oct 14, 2022 | clinicaltrials |
| NCT04178044 | Phase Ⅰ Clinical Study Protocol of GB223 Monoclonal Antibody Injection | unknown | Phase 1 | 44 | Genor Biopharma Co., Ltd.INDUSTRY | 1 | Nov 26, 2019 | clinicaltrials |
| NCT03066245 |
| Use of Stem Cells Cultured on a Scaffold for the Treatment of Aneurysmal Bone Cysts (ABC) |
| unknown |
| Phase 1 / Phase 2 |
| 4 |
| Sophia Al-AdwanOTHER |
| 1 |
| Jul 24, 2019 |
| clinicaltrials |
Data updated 22 days agoSource updated Oct 14, 2022source: clinicaltrials